ACTA1 and idiopathic pulmonary fibrosis: Like the findings with the GPR‐81 antagonist, GPR‐81 silencing clearly reduced α‐SMA levels in control fibroblasts while the levels of α‐SMA remained unaltered in IPF fibroblasts under the same conditions (Figure 8c, upper and lower).